World’s Favourite Talcum Powder Causes Ovarian Cancer in Women

A legal case was slapped against the Johnson & Johnson by a U.S. jury on Monday to pay a sum of $55million to a woman customer who claimed that she got diagnosed for ovarian cancer after using the company’s talc-powder products for feminine hygiene.

The company’s presently legally drowning with 1200 lawsuits filed against accusing them of not adequately warning its consumers of the associated talc-based products cancer risks.

Pursuing the case very closely for three weeks in Missouri state court, jurors settled on the verdict for Gloria Ristesund by awarding her with a $5 million as compensatory damages and $50 million in punitive damages.

J&J spokeswoman Carol Goodrich controverted saying the verdict is trying to disaffirm with the research of 30 years supporting the safety of the cosmetic talc, hence J&J will appeal to fight for its products safety.

Ristesund quoted that she has been an unvarying consumer of the J&J talc- based power products-especially the well known Baby powder and Shower to Shower Powder – on her genitals for decades. She was diagnosed with ovarian cancer and had to undergo hysterectomy and related surgeries. Her cancer is now under control.

The representative of the firm supporting Ristesund, Jere Beasley said that his client was delighted with the verdict; this decision of the jury should bring the litigation to a full stop and should throw weight on the company to settle its remaining cases, he said.

After shock led the company’s share to drop by 18 cents in after – hours trading to $112.57.

The verdict saw the same court in February award a compensation 0f $72 million to the family of a woman who died from ovarian cancer after years of utilizing talc powder for feminine hygiene.

This appeal has reignited the dormant interest in talc-powder lawsuits among the plaintiff’s lawyers; as well users acquainted with J&J powder products. The scientist informed the Reuters that the evidence of a real danger is still ambiguous

Sues in talc lawsuit concentrated in Missouri and New Jersey state courts, have indicted J&J of being incapable in performing its duty of informing its customers about the increased risk for ovarian cancer associated with its talc, whereas J&J has stood for adequate developing and marketing of its products.

Another talc powder and ovarian cancer related case when tried in South Dakota federal court in 2013 eventually concluded in a mixed verdict. The respective jurors found J&J as ignorant and indifferent and awarded no remittance to the plaintiff, whose cancer was under remission at the time of the trial.